Pacific Biosciences of California Inc (NAS:PACB)
$ 1.645 -0.025 (-1.5%) Market Cap: 448.02 Mil Enterprise Value: 817.48 Mil PE Ratio: 0 PB Ratio: 0.69 GF Score: 58/100

Pacific Biosciences of California Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 12, 2023 / 04:55PM GMT
Release Date Price: $10.76 (+3.66%)
Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

Hey, guys. Good afternoon. My name is Tejas Savant, and I'm the life sciences analyst here at Morgan Stanley.

Before we begin, for important disclosures, please see the MS research disclosure website at morganstanley.com/researchdisclosures. If you have any questions, do reach out to your sales rep.

So it's my pleasure this afternoon to host PacBio. And speaking on behalf of the company, we have Christian Henry, CEO. I'm not sure if Susan is here. I guess she's not here. No worries. Thank you for joining us, Christian.

Maybe just to set the stage, it's been a really eventful action packed sort of year for PacBio. Sometimes, some investors feel like you've bitten off more than you can chew because you have all these different initiatives underway. What key accomplishments are you most sort of proud of year-to-date? And what gives you the confidence that you've got this?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot